Industry Research Reports

Home > Reports > Chemical & Material > Global Cardiovascular and Cerebrovascular API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Cardiovascular and Cerebrovascular API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Chemical & Material

Published Date: 2025-09-10

Pages: 97 Pages

Report ld: 4843737

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Cardiovascular and Cerebrovascular API Market Size(US$)

CAGR 2025-2031

2.7%

Market Size,2031

USD 3,893

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 3,318 million

Market Forecast in 2031(Value)

US$ 3,893 million

CAGR

2.7%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Cardiovascular and Cerebrovascular API market size was US$ 3240 million in 2024 and is forecast to a readjusted size of US$ 3893 million by 2031 with a CAGR of 2.7% during the forecast period 2025-2031.

By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Cardiovascular and Cerebrovascular API market competitiveness, regional economic performance, and supply chain configurations.

Cardiovascular disease (CVD) is the leading cause of death in the world. The number of people who die of cardiovascular disease is the largest every year. Cardiovascular drugs are used to treat cardiovascular diseases, including antihypertensive drugs, anti angina drugs, anti heart failure drugs, antiarrhythmic drugs, lipid-lowering drugs and so on. The main raw materials of cardio cerebrovascular drugs include sartan, statins, pril and so on.

China is the main production area of cardiovascular and cerebrovascular raw materials, with a market share of more than 65%, followed by India and Europe.

The key manufacturers are Zhuhai Rundu Pharmaceutical, Ningbo Menovo Pharmaceutical, Zhejiang Huahai Pharmaceutical, Zhejiang Tianyu Pharmaceutical, Zhejiang Hisun Pharmaceutical, Zhejiang Lepu Pharmaceutical, Zhejiang Jiangbei Pharmaceutical, DR.Reddy, Glenmerk, Cipla, MSN Life Sciences etc. Zhejiang Huahai Pharmaceutical Co., Ltd. is the largest producer of cardiovascular and cerebrovascular raw materials in China region market and global market, accounting for more than 10%.

The global Cardiovascular and Cerebrovascular API market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.

MARKET SEGMENTATION

By Company

Zhuhai Rundu Pharmaceutical
Ningbo Menovo Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zhejiang Tianyu Pharmaceutical
Zhejiang Hisun Pharmaceutical
Zhejiang Lepu Pharmaceutical
Zhejiang Jiangbei Pharmaceutical
DR.Reddy
Glenmerk
Cipla
MSN Life Sciences

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Sartans Cardiovascular and Cerebrovascular API
Statins Cardiovascular and Cerebrovascular API
Puri Cardiovascular and Cerebrovascular API

Segment by Application

Oral Drugs
Injection Drugs

biaoTi CHAPTER OUTLINE

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).

Chapter 2: Quantitative analysis of Cardiovascular and Cerebrovascular API market size and growth potential at global, regional, and country levels.

Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).

Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Statins Cardiovascular and Cerebrovascular API in China).

Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Injection Drugs in India).

Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.

Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.

Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 9: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Cardiovascular and Cerebrovascular API value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Cardiovascular and Cerebrovascular API Product Scope

1.2 Cardiovascular and Cerebrovascular API by Type

1.2.1 Global Cardiovascular and Cerebrovascular API Sales by Type (2020 & 2024 & 2031)

1.2.2 Sartans Cardiovascular and Cerebrovascular API

1.2.3 Statins Cardiovascular and Cerebrovascular API

1.2.4 Puri Cardiovascular and Cerebrovascular API

1.3 Cardiovascular and Cerebrovascular API by Application

1.3.1 Global Cardiovascular and Cerebrovascular API Sales Comparison by Application (2020 & 2024 & 2031)

1.3.2 Oral Drugs

1.3.3 Injection Drugs

1.4 Global Cardiovascular and Cerebrovascular API Market Estimates and Forecasts (2020-2031)

1.4.1 Global Cardiovascular and Cerebrovascular API Market Size in Value Growth Rate (2020-2031)

1.4.2 Global Cardiovascular and Cerebrovascular API Market Size in Volume Growth Rate (2020-2031)

1.4.3 Global Cardiovascular and Cerebrovascular API Price Trends (2020-2031)

1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

2.1 Global Cardiovascular and Cerebrovascular API Market Size by Region: 2020 VS 2024 VS 2031

2.2 Global Cardiovascular and Cerebrovascular API Retrospective Market Scenario by Region (2020-2025)

2.2.1 Global Cardiovascular and Cerebrovascular API Sales Market Share by Region (2020-2025)

2.2.2 Global Cardiovascular and Cerebrovascular API Revenue Market Share by Region (2020-2025)

2.3 Global Cardiovascular and Cerebrovascular API Market Estimates and Forecasts by Region (2026-2031)

2.3.1 Global Cardiovascular and Cerebrovascular API Sales Estimates and Forecasts by Region (2026-2031)

2.3.2 Global Cardiovascular and Cerebrovascular API Revenue Forecast by Region (2026-2031)

2.4 Major Region and Emerging Market Analysis

2.4.1 North America Cardiovascular and Cerebrovascular API Market Size and Prospective (2020-2031)

2.4.2 Europe Cardiovascular and Cerebrovascular API Market Size and Prospective (2020-2031)

2.4.3 China Cardiovascular and Cerebrovascular API Market Size and Prospective (2020-2031)

2.4.4 India Cardiovascular and Cerebrovascular API Market Size and Prospective (2020-2031)

3 Global Market Size by Type

3.1 Global Cardiovascular and Cerebrovascular API Historic Market Review by Type (2020-2025)

3.1.1 Global Cardiovascular and Cerebrovascular API Sales by Type (2020-2025)

3.1.2 Global Cardiovascular and Cerebrovascular API Revenue by Type (2020-2025)

3.1.3 Global Cardiovascular and Cerebrovascular API Price by Type (2020-2025)

3.2 Global Cardiovascular and Cerebrovascular API Market Estimates and Forecasts by Type (2026-2031)

3.2.1 Global Cardiovascular and Cerebrovascular API Sales Forecast by Type (2026-2031)

3.2.2 Global Cardiovascular and Cerebrovascular API Revenue Forecast by Type (2026-2031)

3.2.3 Global Cardiovascular and Cerebrovascular API Price Forecast by Type (2026-2031)

3.3 Different Types Cardiovascular and Cerebrovascular API Representative Players

4 Global Market Size by Application

4.1 Global Cardiovascular and Cerebrovascular API Historic Market Review by Application (2020-2025)

4.1.1 Global Cardiovascular and Cerebrovascular API Sales by Application (2020-2025)

4.1.2 Global Cardiovascular and Cerebrovascular API Revenue by Application (2020-2025)

4.1.3 Global Cardiovascular and Cerebrovascular API Price by Application (2020-2025)

4.2 Global Cardiovascular and Cerebrovascular API Market Estimates and Forecasts by Application (2026-2031)

4.2.1 Global Cardiovascular and Cerebrovascular API Sales Forecast by Application (2026-2031)

4.2.2 Global Cardiovascular and Cerebrovascular API Revenue Forecast by Application (2026-2031)

4.2.3 Global Cardiovascular and Cerebrovascular API Price Forecast by Application (2026-2031)

4.3 New Sources of Growth in Cardiovascular and Cerebrovascular API Application

5 Competition Landscape by Players

5.1 Global Cardiovascular and Cerebrovascular API Sales by Players (2020-2025)

5.2 Global Top Cardiovascular and Cerebrovascular API Players by Revenue (2020-2025)

5.3 Global Cardiovascular and Cerebrovascular API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiovascular and Cerebrovascular API as of 2024)

5.4 Global Cardiovascular and Cerebrovascular API Average Price by Company (2020-2025)

5.5 Global Key Manufacturers of Cardiovascular and Cerebrovascular API, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Cardiovascular and Cerebrovascular API, Product Type & Application

5.7 Global Key Manufacturers of Cardiovascular and Cerebrovascular API, Date of Enter into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Cardiovascular and Cerebrovascular API Sales by Company

6.1.1.1 North America Cardiovascular and Cerebrovascular API Sales by Company (2020-2025)

6.1.1.2 North America Cardiovascular and Cerebrovascular API Revenue by Company (2020-2025)

6.1.2 North America Cardiovascular and Cerebrovascular API Sales Breakdown by Type (2020-2025)

6.1.3 North America Cardiovascular and Cerebrovascular API Sales Breakdown by Application (2020-2025)

6.1.4 North America Cardiovascular and Cerebrovascular API Major Customer

6.1.5 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Cardiovascular and Cerebrovascular API Sales by Company

6.2.1.1 Europe Cardiovascular and Cerebrovascular API Sales by Company (2020-2025)

6.2.1.2 Europe Cardiovascular and Cerebrovascular API Revenue by Company (2020-2025)

6.2.2 Europe Cardiovascular and Cerebrovascular API Sales Breakdown by Type (2020-2025)

6.2.3 Europe Cardiovascular and Cerebrovascular API Sales Breakdown by Application (2020-2025)

6.2.4 Europe Cardiovascular and Cerebrovascular API Major Customer

6.2.5 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Cardiovascular and Cerebrovascular API Sales by Company

6.3.1.1 China Cardiovascular and Cerebrovascular API Sales by Company (2020-2025)

6.3.1.2 China Cardiovascular and Cerebrovascular API Revenue by Company (2020-2025)

6.3.2 China Cardiovascular and Cerebrovascular API Sales Breakdown by Type (2020-2025)

6.3.3 China Cardiovascular and Cerebrovascular API Sales Breakdown by Application (2020-2025)

6.3.4 China Cardiovascular and Cerebrovascular API Major Customer

6.3.5 China Market Trend and Opportunities

6.4 India Market: Players, Segments, Downstream and Major Customers

6.4.1 India Cardiovascular and Cerebrovascular API Sales by Company

6.4.1.1 India Cardiovascular and Cerebrovascular API Sales by Company (2020-2025)

6.4.1.2 India Cardiovascular and Cerebrovascular API Revenue by Company (2020-2025)

6.4.2 India Cardiovascular and Cerebrovascular API Sales Breakdown by Type (2020-2025)

6.4.3 India Cardiovascular and Cerebrovascular API Sales Breakdown by Application (2020-2025)

6.4.4 India Cardiovascular and Cerebrovascular API Major Customer

6.4.5 India Market Trend and Opportunities

7 Company Profiles and Key Figures

7.1 Zhuhai Rundu Pharmaceutical

7.1.1 Zhuhai Rundu Pharmaceutical Company Information

7.1.2 Zhuhai Rundu Pharmaceutical Business Overview

7.1.3 Zhuhai Rundu Pharmaceutical Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2020-2025)

7.1.4 Zhuhai Rundu Pharmaceutical Cardiovascular and Cerebrovascular API Products Offered

7.1.5 Zhuhai Rundu Pharmaceutical Recent Development

7.2 Ningbo Menovo Pharmaceutical

7.2.1 Ningbo Menovo Pharmaceutical Company Information

7.2.2 Ningbo Menovo Pharmaceutical Business Overview

7.2.3 Ningbo Menovo Pharmaceutical Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2020-2025)

7.2.4 Ningbo Menovo Pharmaceutical Cardiovascular and Cerebrovascular API Products Offered

7.2.5 Ningbo Menovo Pharmaceutical Recent Development

7.3 Zhejiang Huahai Pharmaceutical

7.3.1 Zhejiang Huahai Pharmaceutical Company Information

7.3.2 Zhejiang Huahai Pharmaceutical Business Overview

7.3.3 Zhejiang Huahai Pharmaceutical Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2020-2025)

7.3.4 Zhejiang Huahai Pharmaceutical Cardiovascular and Cerebrovascular API Products Offered

7.3.5 Zhejiang Huahai Pharmaceutical Recent Development

7.4 Zhejiang Tianyu Pharmaceutical

7.4.1 Zhejiang Tianyu Pharmaceutical Company Information

7.4.2 Zhejiang Tianyu Pharmaceutical Business Overview

7.4.3 Zhejiang Tianyu Pharmaceutical Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2020-2025)

7.4.4 Zhejiang Tianyu Pharmaceutical Cardiovascular and Cerebrovascular API Products Offered

7.4.5 Zhejiang Tianyu Pharmaceutical Recent Development

7.5 Zhejiang Hisun Pharmaceutical

7.5.1 Zhejiang Hisun Pharmaceutical Company Information

7.5.2 Zhejiang Hisun Pharmaceutical Business Overview

7.5.3 Zhejiang Hisun Pharmaceutical Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2020-2025)

7.5.4 Zhejiang Hisun Pharmaceutical Cardiovascular and Cerebrovascular API Products Offered

7.5.5 Zhejiang Hisun Pharmaceutical Recent Development

7.6 Zhejiang Lepu Pharmaceutical

7.6.1 Zhejiang Lepu Pharmaceutical Company Information

7.6.2 Zhejiang Lepu Pharmaceutical Business Overview

7.6.3 Zhejiang Lepu Pharmaceutical Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2020-2025)

7.6.4 Zhejiang Lepu Pharmaceutical Cardiovascular and Cerebrovascular API Products Offered

7.6.5 Zhejiang Lepu Pharmaceutical Recent Development

7.7 Zhejiang Jiangbei Pharmaceutical

7.7.1 Zhejiang Jiangbei Pharmaceutical Company Information

7.7.2 Zhejiang Jiangbei Pharmaceutical Business Overview

7.7.3 Zhejiang Jiangbei Pharmaceutical Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2020-2025)

7.7.4 Zhejiang Jiangbei Pharmaceutical Cardiovascular and Cerebrovascular API Products Offered

7.7.5 Zhejiang Jiangbei Pharmaceutical Recent Development

7.8 DR.Reddy

7.8.1 DR.Reddy Company Information

7.8.2 DR.Reddy Business Overview

7.8.3 DR.Reddy Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2020-2025)

7.8.4 DR.Reddy Cardiovascular and Cerebrovascular API Products Offered

7.8.5 DR.Reddy Recent Development

7.9 Glenmerk

7.9.1 Glenmerk Company Information

7.9.2 Glenmerk Business Overview

7.9.3 Glenmerk Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2020-2025)

7.9.4 Glenmerk Cardiovascular and Cerebrovascular API Products Offered

7.9.5 Glenmerk Recent Development

7.10 Cipla

7.10.1 Cipla Company Information

7.10.2 Cipla Business Overview

7.10.3 Cipla Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2020-2025)

7.10.4 Cipla Cardiovascular and Cerebrovascular API Products Offered

7.10.5 Cipla Recent Development

7.11 MSN Life Sciences

7.11.1 MSN Life Sciences Company Information

7.11.2 MSN Life Sciences Business Overview

7.11.3 MSN Life Sciences Cardiovascular and Cerebrovascular API Sales, Revenue and Gross Margin (2020-2025)

7.11.4 MSN Life Sciences Cardiovascular and Cerebrovascular API Products Offered

7.11.5 MSN Life Sciences Recent Development

8 Cardiovascular and Cerebrovascular API Manufacturing Cost Analysis

8.1 Cardiovascular and Cerebrovascular API Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Cardiovascular and Cerebrovascular API

8.4 Cardiovascular and Cerebrovascular API Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Cardiovascular and Cerebrovascular API Distributors List

9.3 Cardiovascular and Cerebrovascular API Customers

10 Cardiovascular and Cerebrovascular API Market Dynamics

10.1 Cardiovascular and Cerebrovascular API Industry Trends

10.2 Cardiovascular and Cerebrovascular API Market Drivers

10.3 Cardiovascular and Cerebrovascular API Market Challenges

10.4 Cardiovascular and Cerebrovascular API Market Restraints

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Cardiovascular and Cerebrovascular API Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Cardiovascular and Cerebrovascular API Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Cardiovascular and Cerebrovascular API Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Cardiovascular and Cerebrovascular API Sales (MT) by Region (2020-2025)

Table 5. Global Cardiovascular and Cerebrovascular API Sales Market Share by Region (2020-2025)

Table 6. Global Cardiovascular and Cerebrovascular API Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Cardiovascular and Cerebrovascular API Revenue Share by Region (2020-2025)

Table 8. Global Cardiovascular and Cerebrovascular API Sales (MT) Forecast by Region (2026-2031)

Table 9. Global Cardiovascular and Cerebrovascular API Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Cardiovascular and Cerebrovascular API Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Cardiovascular and Cerebrovascular API Revenue Share Forecast by Region (2026-2031)

Table 12. Global Cardiovascular and Cerebrovascular API Sales by Type (MT) & (2020-2025)

Table 13. Global Cardiovascular and Cerebrovascular API Sales Share by Type (2020-2025)

Table 14. Global Cardiovascular and Cerebrovascular API Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Cardiovascular and Cerebrovascular API Price by Type (USD/Kg) & (2020-2025)

Table 16. Global Cardiovascular and Cerebrovascular API Sales by Type (MT) & (2026-2031)

Table 17. Global Cardiovascular and Cerebrovascular API Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Cardiovascular and Cerebrovascular API Price by Type (USD/Kg) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Cardiovascular and Cerebrovascular API Sales by Application (MT) & (2020-2025)

Table 21. Global Cardiovascular and Cerebrovascular API Sales Share by Application (2020-2025)

Table 22. Global Cardiovascular and Cerebrovascular API Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Cardiovascular and Cerebrovascular API Price by Application (USD/Kg) & (2020-2025)

Table 24. Global Cardiovascular and Cerebrovascular API Sales by Application (MT) & (2026-2031)

Table 25. Global Cardiovascular and Cerebrovascular API Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Cardiovascular and Cerebrovascular API Price by Application (USD/Kg) & (2026-2031)

Table 27. New Sources of Growth in Cardiovascular and Cerebrovascular API Application

Table 28. Global Cardiovascular and Cerebrovascular API Sales by Company (MT) & (2020-2025)

Table 29. Global Cardiovascular and Cerebrovascular API Sales Share by Company (2020-2025)

Table 30. Global Cardiovascular and Cerebrovascular API Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Cardiovascular and Cerebrovascular API Revenue Share by Company (2020-2025)

Table 32. Global Cardiovascular and Cerebrovascular API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiovascular and Cerebrovascular API as of 2024)

Table 33. Global Market Cardiovascular and Cerebrovascular API Average Price by Company (USD/Kg) & (2020-2025)

Table 34. Global Key Manufacturers of Cardiovascular and Cerebrovascular API, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Cardiovascular and Cerebrovascular API, Product Type & Application

Table 36. Global Key Manufacturers of Cardiovascular and Cerebrovascular API, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Cardiovascular and Cerebrovascular API Sales by Company (2020-2025) & (MT)

Table 39. North America Cardiovascular and Cerebrovascular API Sales Market Share by Company (2020-2025)

Table 40. North America Cardiovascular and Cerebrovascular API Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America Cardiovascular and Cerebrovascular API Revenue Market Share by Company (2020-2025)

Table 42. North America Cardiovascular and Cerebrovascular API Sales by Type (2020-2025) & (MT)

Table 43. North America Cardiovascular and Cerebrovascular API Sales Market Share by Type (2020-2025)

Table 44. North America Cardiovascular and Cerebrovascular API Sales by Application (2020-2025) & (MT)

Table 45. North America Cardiovascular and Cerebrovascular API Sales Market Share by Application (2020-2025)

Table 46. Europe Cardiovascular and Cerebrovascular API Sales by Company (2020-2025) & (MT)

Table 47. Europe Cardiovascular and Cerebrovascular API Sales Market Share by Company (2020-2025)

Table 48. Europe Cardiovascular and Cerebrovascular API Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe Cardiovascular and Cerebrovascular API Revenue Market Share by Company (2020-2025)

Table 50. Europe Cardiovascular and Cerebrovascular API Sales by Type (2020-2025) & (MT)

Table 51. Europe Cardiovascular and Cerebrovascular API Sales Market Share by Type (2020-2025)

Table 52. Europe Cardiovascular and Cerebrovascular API Sales by Application (2020-2025) & (MT)

Table 53. Europe Cardiovascular and Cerebrovascular API Sales Market Share by Application (2020-2025)

Table 54. China Cardiovascular and Cerebrovascular API Sales by Company (2020-2025) & (MT)

Table 55. China Cardiovascular and Cerebrovascular API Sales Market Share by Company (2020-2025)

Table 56. China Cardiovascular and Cerebrovascular API Revenue by Company (2020-2025) & (US$ Million)

Table 57. China Cardiovascular and Cerebrovascular API Revenue Market Share by Company (2020-2025)

Table 58. China Cardiovascular and Cerebrovascular API Sales by Type (2020-2025) & (MT)

Table 59. China Cardiovascular and Cerebrovascular API Sales Market Share by Type (2020-2025)

Table 60. China Cardiovascular and Cerebrovascular API Sales by Application (2020-2025) & (MT)

Table 61. China Cardiovascular and Cerebrovascular API Sales Market Share by Application (2020-2025)

Table 62. India Cardiovascular and Cerebrovascular API Sales by Company (2020-2025) & (MT)

Table 63. India Cardiovascular and Cerebrovascular API Sales Market Share by Company (2020-2025)

Table 64. India Cardiovascular and Cerebrovascular API Revenue by Company (2020-2025) & (US$ Million)

Table 65. India Cardiovascular and Cerebrovascular API Revenue Market Share by Company (2020-2025)

Table 66. India Cardiovascular and Cerebrovascular API Sales by Type (2020-2025) & (MT)

Table 67. India Cardiovascular and Cerebrovascular API Sales Market Share by Type (2020-2025)

Table 68. India Cardiovascular and Cerebrovascular API Sales by Application (2020-2025) & (MT)

Table 69. India Cardiovascular and Cerebrovascular API Sales Market Share by Application (2020-2025)

Table 70. Zhuhai Rundu Pharmaceutical Company Information

Table 71. Zhuhai Rundu Pharmaceutical Description and Business Overview

Table 72. Zhuhai Rundu Pharmaceutical Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 73. Zhuhai Rundu Pharmaceutical Cardiovascular and Cerebrovascular API Product

Table 74. Zhuhai Rundu Pharmaceutical Recent Development

Table 75. Ningbo Menovo Pharmaceutical Company Information

Table 76. Ningbo Menovo Pharmaceutical Description and Business Overview

Table 77. Ningbo Menovo Pharmaceutical Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 78. Ningbo Menovo Pharmaceutical Cardiovascular and Cerebrovascular API Product

Table 79. Ningbo Menovo Pharmaceutical Recent Development

Table 80. Zhejiang Huahai Pharmaceutical Company Information

Table 81. Zhejiang Huahai Pharmaceutical Description and Business Overview

Table 82. Zhejiang Huahai Pharmaceutical Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 83. Zhejiang Huahai Pharmaceutical Cardiovascular and Cerebrovascular API Product

Table 84. Zhejiang Huahai Pharmaceutical Recent Development

Table 85. Zhejiang Tianyu Pharmaceutical Company Information

Table 86. Zhejiang Tianyu Pharmaceutical Description and Business Overview

Table 87. Zhejiang Tianyu Pharmaceutical Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 88. Zhejiang Tianyu Pharmaceutical Cardiovascular and Cerebrovascular API Product

Table 89. Zhejiang Tianyu Pharmaceutical Recent Development

Table 90. Zhejiang Hisun Pharmaceutical Company Information

Table 91. Zhejiang Hisun Pharmaceutical Description and Business Overview

Table 92. Zhejiang Hisun Pharmaceutical Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 93. Zhejiang Hisun Pharmaceutical Cardiovascular and Cerebrovascular API Product

Table 94. Zhejiang Hisun Pharmaceutical Recent Development

Table 95. Zhejiang Lepu Pharmaceutical Company Information

Table 96. Zhejiang Lepu Pharmaceutical Description and Business Overview

Table 97. Zhejiang Lepu Pharmaceutical Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 98. Zhejiang Lepu Pharmaceutical Cardiovascular and Cerebrovascular API Product

Table 99. Zhejiang Lepu Pharmaceutical Recent Development

Table 100. Zhejiang Jiangbei Pharmaceutical Company Information

Table 101. Zhejiang Jiangbei Pharmaceutical Description and Business Overview

Table 102. Zhejiang Jiangbei Pharmaceutical Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 103. Zhejiang Jiangbei Pharmaceutical Cardiovascular and Cerebrovascular API Product

Table 104. Zhejiang Jiangbei Pharmaceutical Recent Development

Table 105. DR.Reddy Company Information

Table 106. DR.Reddy Description and Business Overview

Table 107. DR.Reddy Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 108. DR.Reddy Cardiovascular and Cerebrovascular API Product

Table 109. DR.Reddy Recent Development

Table 110. Glenmerk Company Information

Table 111. Glenmerk Description and Business Overview

Table 112. Glenmerk Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 113. Glenmerk Cardiovascular and Cerebrovascular API Product

Table 114. Glenmerk Recent Development

Table 115. Cipla Company Information

Table 116. Cipla Description and Business Overview

Table 117. Cipla Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 118. Cipla Cardiovascular and Cerebrovascular API Product

Table 119. Cipla Recent Development

Table 120. MSN Life Sciences Company Information

Table 121. MSN Life Sciences Description and Business Overview

Table 122. MSN Life Sciences Cardiovascular and Cerebrovascular API Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 123. MSN Life Sciences Cardiovascular and Cerebrovascular API Product

Table 124. MSN Life Sciences Recent Development

Table 125. Production Base and Market Concentration Rate of Raw Material

Table 126. Key Suppliers of Raw Materials

Table 127. Cardiovascular and Cerebrovascular API Distributors List

Table 128. Cardiovascular and Cerebrovascular API Customers List

Table 129. Cardiovascular and Cerebrovascular API Market Trends

Table 130. Cardiovascular and Cerebrovascular API Market Drivers

Table 131. Cardiovascular and Cerebrovascular API Market Challenges

Table 132. Cardiovascular and Cerebrovascular API Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Cardiovascular and Cerebrovascular API Product Picture

Figure 2. Global Cardiovascular and Cerebrovascular API Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Cardiovascular and Cerebrovascular API Sales Market Share by Type in 2024 & 2031

Figure 4. Sartans Cardiovascular and Cerebrovascular API Product Picture

Figure 5. Statins Cardiovascular and Cerebrovascular API Product Picture

Figure 6. Puri Cardiovascular and Cerebrovascular API Product Picture

Figure 7. Global Cardiovascular and Cerebrovascular API Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 8. Global Cardiovascular and Cerebrovascular API Sales Market Share by Application in 2024 & 2031

Figure 9. Oral Drugs Examples

Figure 10. Injection Drugs Examples

Figure 11. Global Cardiovascular and Cerebrovascular API Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Cardiovascular and Cerebrovascular API Sales Growth Rate (2020-2031) & (US$ Million)

Figure 13. Global Cardiovascular and Cerebrovascular API Sales (MT) Growth Rate (2020-2031)

Figure 14. Global Cardiovascular and Cerebrovascular API Price Trends Growth Rate (2020-2031) & (USD/Kg)

Figure 15. Cardiovascular and Cerebrovascular API Report Years Considered

Figure 16. Global Market Cardiovascular and Cerebrovascular API Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 17. Global Cardiovascular and Cerebrovascular API Revenue Market Share by Region: 2020 VS 2024

Figure 18. North America Cardiovascular and Cerebrovascular API Revenue (US$ Million) Growth Rate (2020-2031)

Figure 19. North America Cardiovascular and Cerebrovascular API Sales (MT) Growth Rate (2020-2031)

Figure 20. Europe Cardiovascular and Cerebrovascular API Revenue (US$ Million) Growth Rate (2020-2031)

Figure 21. Europe Cardiovascular and Cerebrovascular API Sales (MT) Growth Rate (2020-2031)

Figure 22. China Cardiovascular and Cerebrovascular API Revenue (US$ Million) Growth Rate (2020-2031)

Figure 23. China Cardiovascular and Cerebrovascular API Sales (MT) Growth Rate (2020-2031)

Figure 24. India Cardiovascular and Cerebrovascular API Revenue (US$ Million) Growth Rate (2020-2031)

Figure 25. India Cardiovascular and Cerebrovascular API Sales (MT) Growth Rate (2020-2031)

Figure 26. Global Cardiovascular and Cerebrovascular API Revenue Share by Type (2020-2025)

Figure 27. Global Cardiovascular and Cerebrovascular API Sales Share by Type (2026-2031)

Figure 28. Global Cardiovascular and Cerebrovascular API Revenue Share by Type (2026-2031)

Figure 29. Global Cardiovascular and Cerebrovascular API Revenue Share by Application (2020-2025)

Figure 30. Global Cardiovascular and Cerebrovascular API Revenue Growth Rate by Application in 2020 & 2024

Figure 31. Global Cardiovascular and Cerebrovascular API Sales Share by Application (2026-2031)

Figure 32. Global Cardiovascular and Cerebrovascular API Revenue Share by Application (2026-2031)

Figure 33. Global Cardiovascular and Cerebrovascular API Sales Share by Company (2024)

Figure 34. Global Cardiovascular and Cerebrovascular API Revenue Share by Company (2024)

Figure 35. Global 5 Largest Cardiovascular and Cerebrovascular API Players Market Share by Revenue in Cardiovascular and Cerebrovascular API: 2020 & 2024

Figure 36. Cardiovascular and Cerebrovascular API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 37. Manufacturing Cost Structure of Cardiovascular and Cerebrovascular API

Figure 38. Manufacturing Process Analysis of Cardiovascular and Cerebrovascular API

Figure 39. Cardiovascular and Cerebrovascular API Industrial Chain

Figure 40. Channels of Distribution (Direct Vs Distribution)

Figure 41. Distributors Profiles

Figure 42. Bottom-up and Top-down Approaches for This Report

Figure 43. Data Triangulation

Figure 44. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Cardiovascular and Cerebrovascular API in 2031? zhanKai

The global market size of Cardiovascular and Cerebrovascular API in 2031 was 3893 Million USD.

Which companies rank high in the global Cardiovascular and Cerebrovascular API market? shouQi

What is the annual compound growth rate of the global Cardiovascular and Cerebrovascular API market size from 2025 to 2031? shouQi

What was the global market size of Cardiovascular and Cerebrovascular API in 2025? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Global Cardiovascular and Cerebrovascular API Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cardiovascular and Cerebrovascular API market size was US$ 3318 million in 2025 and is forecast to reach a readjusted size of US$ 3988 million by 2032 with a CAGR of 2.7% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 100
USD 4250.00
(Single User License)
Global Cardiovascular and Cerebrovascular API Market Research Report 2026
The global Cardiovascular and Cerebrovascular API market was valued at US$ 3318 million in 2025 and is anticipated to reach US$ 3988 million by 2032, at a CAGR of 2.7% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 144
USD 2900.00
(Single User License)
Cardiovascular and Cerebrovascular API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cardiovascular and Cerebrovascular API was estimated to be worth US$ 3318 million in 2025 and is projected to reach US$ 3988 million, growing at a CAGR of 2.7% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 114
USD 3950.00
(Single User License)
Global Cardiovascular and Cerebrovascular API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cardiovascular and Cerebrovascular API market is projected to grow from US$ 3240 million in 2024 to US$ 3893 million by 2031, at a CAGR of 2.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-08
Pages: 154
USD 4900.00
(Single User License)
Cardiovascular and Cerebrovascular API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cardiovascular and Cerebrovascular API was estimated to be worth US$ 3240 million in 2024 and is forecast to a readjusted size of US$ 3893 million by 2031 with a CAGR of 2.7% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 113
USD 3950.00
(Single User License)
Global Cardiovascular and Cerebrovascular API Market Research Report 2025
The global market for Cardiovascular and Cerebrovascular API was valued at US$ 3240 million in the year 2024 and is projected to reach a revised size of US$ 3893 million by 2031, growing at a CAGR of 2.7% during the forecast period.
Published Date: 2025-01-19
Pages: 102
USD 2900.00
(Single User License)
Global Cardiovascular and Cerebrovascular API Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Cardiovascular disease (CVD) is the leading cause of death in the world. The number of people who die of cardiovascular disease is the largest every year. Cardiovascular drugs are used to treat cardiovascular diseases, including antihypertensive drugs, anti angina drugs, anti heart failure drugs, antiarrhythmic drugs, lipid-lowering drugs and so on. The main raw materials of cardio cerebrovascular drugs include sartan, statins, pril and so on.
Published Date: 2024-04-17
Pages: 175
USD 5600.00
(Single User License)
Global Cardiovascular and Cerebrovascular API Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Cardiovascular disease (CVD) is the leading cause of death in the world. The number of people who die of cardiovascular disease is the largest every year. Cardiovascular drugs are used to treat cardiovascular diseases, including antihypertensive drugs, anti angina drugs, anti heart failure drugs, antiarrhythmic drugs, lipid-lowering drugs and so on. The main raw materials of cardio cerebrovascular drugs include sartan, statins, pril and so on.
Published Date: 2024-04-16
Pages: 153
USD 5900.00
(Single User License)
Global Cardiovascular and Cerebrovascular API Market Insights, Forecast to 2030
Cardiovascular disease (CVD) is the leading cause of death in the world. The number of people who die of cardiovascular disease is the largest every year. Cardiovascular drugs are used to treat cardiovascular diseases, including antihypertensive drugs, anti angina drugs, anti heart failure drugs, antiarrhythmic drugs, lipid-lowering drugs and so on. The main raw materials of cardio cerebrovascular drugs include sartan, statins, pril and so on.
Published Date: 2024-04-07
Pages: 110
USD 4900.00
(Single User License)
Cardiovascular and Cerebrovascular API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Cardiovascular disease (CVD) is the leading cause of death in the world. The number of people who die of cardiovascular disease is the largest every year. Cardiovascular drugs are used to treat cardiovascular diseases, including antihypertensive drugs, anti angina drugs, anti heart failure drugs, antiarrhythmic drugs, lipid-lowering drugs and so on. The main raw materials of cardio cerebrovascular drugs include sartan, statins, pril and so on.
Published Date: 2024-01-18
Pages: 123
USD 3950.00
(Single User License)

Global Cardiovascular and Cerebrovascular API Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cardiovascular and Cerebrovascular API market size was US$ 3318 million in 2025 and is forecast to reach a readjusted size of US$ 3988 million by 2032 with a CAGR of 2.7% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 100
USD 4250.00 (Single User License)
Global Cardiovascular and Cerebrovascular API Market Research Report 2026
The global Cardiovascular and Cerebrovascular API market was valued at US$ 3318 million in 2025 and is anticipated to reach US$ 3988 million by 2032, at a CAGR of 2.7% from 2026 to 2032.
Published: 2026-01-05
Pages: 144
USD 2900.00 (Single User License)
Cardiovascular and Cerebrovascular API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cardiovascular and Cerebrovascular API was estimated to be worth US$ 3318 million in 2025 and is projected to reach US$ 3988 million, growing at a CAGR of 2.7% from 2026 to 2032.
Published: 2026-01-05
Pages: 114
USD 3950.00 (Single User License)
Global Cardiovascular and Cerebrovascular API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cardiovascular and Cerebrovascular API market is projected to grow from US$ 3240 million in 2024 to US$ 3893 million by 2031, at a CAGR of 2.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-08
Pages: 154
USD 4900.00 (Single User License)
Cardiovascular and Cerebrovascular API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cardiovascular and Cerebrovascular API was estimated to be worth US$ 3240 million in 2024 and is forecast to a readjusted size of US$ 3893 million by 2031 with a CAGR of 2.7% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 113
USD 3950.00 (Single User License)
Global Cardiovascular and Cerebrovascular API Market Research Report 2025
The global market for Cardiovascular and Cerebrovascular API was valued at US$ 3240 million in the year 2024 and is projected to reach a revised size of US$ 3893 million by 2031, growing at a CAGR of 2.7% during the forecast period.
Published: 2025-01-19
Pages: 102
USD 2900.00 (Single User License)
Global Cardiovascular and Cerebrovascular API Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Cardiovascular disease (CVD) is the leading cause of death in the world. The number of people who die of cardiovascular disease is the largest every year. Cardiovascular drugs are used to treat cardiovascular diseases, including antihypertensive drugs, anti angina drugs, anti heart failure drugs, antiarrhythmic drugs, lipid-lowering drugs and so on. The main raw materials of cardio cerebrovascular drugs include sartan, statins, pril and so on.
Published: 2024-04-17
Pages: 175
USD 5600.00 (Single User License)
Global Cardiovascular and Cerebrovascular API Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Cardiovascular disease (CVD) is the leading cause of death in the world. The number of people who die of cardiovascular disease is the largest every year. Cardiovascular drugs are used to treat cardiovascular diseases, including antihypertensive drugs, anti angina drugs, anti heart failure drugs, antiarrhythmic drugs, lipid-lowering drugs and so on. The main raw materials of cardio cerebrovascular drugs include sartan, statins, pril and so on.
Published: 2024-04-16
Pages: 153
USD 5900.00 (Single User License)
Global Cardiovascular and Cerebrovascular API Market Insights, Forecast to 2030
Cardiovascular disease (CVD) is the leading cause of death in the world. The number of people who die of cardiovascular disease is the largest every year. Cardiovascular drugs are used to treat cardiovascular diseases, including antihypertensive drugs, anti angina drugs, anti heart failure drugs, antiarrhythmic drugs, lipid-lowering drugs and so on. The main raw materials of cardio cerebrovascular drugs include sartan, statins, pril and so on.
Published: 2024-04-07
Pages: 110
USD 4900.00 (Single User License)
Cardiovascular and Cerebrovascular API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Cardiovascular disease (CVD) is the leading cause of death in the world. The number of people who die of cardiovascular disease is the largest every year. Cardiovascular drugs are used to treat cardiovascular diseases, including antihypertensive drugs, anti angina drugs, anti heart failure drugs, antiarrhythmic drugs, lipid-lowering drugs and so on. The main raw materials of cardio cerebrovascular drugs include sartan, statins, pril and so on.
Published: 2024-01-18
Pages: 123
USD 3950.00 (Single User License)